Early selexipag initiation and long-term outcomes: insights from randomised controlled trials in pulmonary arterial hypertension

Further understanding of when to initiate therapies in pulmonary arterial hypertension (PAH) is important to improve long-term outcomes. Post hoc analyses of GRIPHON (NCT01106014) and exploratory analyses of TRITON (NCT02558231) suggested benefit of early selexipag initiation on long-term outcomes,...

Descripción completa

Detalles Bibliográficos
Autores principales: Coghlan, J. Gerry, Gaine, Sean, Channick, Richard, Chin, Kelly M., du Roure, Camille, Gibbs, J. Simon R., Hoeper, Marius M., Lang, Irene M., Mathai, Stephen C., McLaughlin, Vallerie V., Mitchell, Lada, Simonneau, Gérald, Sitbon, Olivier, Tapson, Victor F., Galiè, Nazzareno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841313/
https://www.ncbi.nlm.nih.gov/pubmed/36687361
http://dx.doi.org/10.1183/23120541.00456-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841313/
https://www.ncbi.nlm.nih.gov/pubmed/36687361
http://dx.doi.org/10.1183/23120541.00456-2022

Ejemplares similares